Danaher
In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) for $180.00 per share in an all-cash transaction. The deal, valued at approximately $9.
Danaher
New York, NY – December 9, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share. This declaration, coming on the heels of a consistently strong financial performance, reaffirms the company&
Danaher
New York, NY – October 1, 2025 – Shares of Danaher Corporation (NYSE: DHR) surged by a robust 6.6% today, following a significant announcement from its life sciences subsidiary, Leica Biosystems. The unveiling of an expanded suite of artificial intelligence (AI)-powered digital pathology solutions has sent a clear signal to